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Abstract
Background: The EVERREST Prospective Study is a multicentre observational cohort study of pregnancies affected
by severe early-onset fetal growth restriction. The study recruits women with singleton pregnancies where the
estimated fetal weight is less than the 3rd centile and below 600 g, between 20 + 0 and 26 + 6 weeks of pregnancy,
in the absence of a known chromosomal, structural or infective cause.
Method: The reported study was retrospective descriptive qualitative interview study of women who had
participated in the EVERREST Prospective Study. The aim of this study was to explore the experiences and
perceptions of pregnant women taking part in research during a pregnancy affected by severe early-onset fetal
growth restriction. Audio-recorded semi-structured telephone interviews were conducted with a purposive sample
of 12 women, at least 1 year after delivery of their baby. Two of these pregnancies had ended in stillbirth and one
in neonatal death, reflecting the outcomes seen in the EVERREST Prospective Study. Participants gave informed
consent, were 16 years or older and were interviewed in English. A topic guide was used to ensure a consistent
approach. Questions focused on pregnancy experiences, involvement with the EVERREST study and potential
involvement in future research. Recordings were transcribed verbatim for thematic analysis using NVivo10.
Results: Four broad themes were identified; ‘before joining the EVERREST Prospective Study’, ‘participating in
research’, ‘information and support’ and ‘looking back and looking forwards’. Each broad theme incorporated
several subthemes. All participants recalled their reaction to being told their baby was smaller than expected. The
way this news was given had a lasting impact. A range of benefits of participation in the EVERREST Prospective
Study were described and the participants were positive about the way it was conducted. As a consequence, they
were receptive to participating in future research. However, the findings suggest that research teams should be
sensitive when approaching families at a difficult time or when they are already participating in other research.
Conclusions: This study highlights the willingness of pregnant women to participate in research and identifies
strategies for researchers to engage participants.
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Background
Fetal growth restriction (FGR) affects 8% of pregnancies and
accounts for 30% of stillbirths [1]. Severe early-onset FGR
occurs before 28weeks gestation and is most commonly due
to insufficient utero-placental blood flow termed placental
insufficiency. As no treatment is currently available to im-
prove fetal growth, management is delivery of the baby be-
fore intrauterine death or permanent organ damage [2]. A
potential treatment for FGR is maternal gene therapy which
aims to increase the local availability of Vascular Endothelial
Growth Factor (VEGF) in the maternal uteroplacental circu-
lation. Preclinical studies have shown that maternal uterine
artery administration of adenovirus vectors containing the
VEGF gene in pregnancy increases uterine blood flow, angio-
genesis and fetal growth [3–6].
The EVERREST Project intends to perform a phase I/
IIa trial of maternal VEGF gene therapy for severe
early-onset FGR [7]. As the primary outcome will be to es-
tablish the safety of the intervention, it will aim to recruit
women for whom the risks of fetal of neonatal death are
high enough to justify potential risks [8]. These women
will therefore face the psychological and emotional impact
of the diagnosis and prognosis as well as potential clinical
trial participation. The EVERREST Clinical Trial will be a
dose-escalation trial and will not include a placebo arm.
It is fundamental to the ethical conduct of medical re-
search that the potential benefits of a trial must be weighed
against the risks and burdens for the participant [9, 10]. This
is more than just the physical risks of any procedure or
medication, and may include the burden of time taken to
participate or the emotional impact of taking part in the re-
search. When weighing these risks, researchers and Research
Ethics Committees use a combination of “common sense,
clinical judgement, prior experience, imagined personal sub-
stitution with the participant, and multidisciplinary consult-
ation” [11]. These strategies have the potential to either over-
or underestimate the burdens a trial places on participants,
depending on the opinions and assumptions of those in-
volved. This could be particularly relevant to the EVERREST
Clinical Trial, where the clinical situation already places prac-
tical and emotional burdens on women.
In recent years increasing attention has been paid to
women’s experiences of participating in research during
pregnancy [12–17]. Many of the findings of these studies
can be generalised to wider obstetric research, however
some of their findings will inherently be specific to the trial
or study in which the women participated. Furthermore,
while many studies have used a qualitative approach to ex-
plore women’s experiences of pregnancy, including high
risk and complicated pregnancies [18–22], we were unable
to identify any studies that had addressed the experience of
women with pregnancies complicated by FGR. In previous
work by the EVERREST Consortium we had explored the
attitudes of women and couples with previous pregnancies
affected by severe early-onset FGR towards research in
pregnancy [23]. We now wanted to investigate the experi-
ence of women with pregnancies affected by severe
early-onset FGR who had taken part in clinical research.
In order to provide comparison data on untreated preg-
nancies for the future EVERREST Clinical Trial, the EVERR-
EST Prospective Study was launched in March 2014 [7].
This recruits women with singleton pregnancies where the
estimated fetal weight (EFW) is below the 3rd centile and
below 600 g, between 20 + 0 and 26 + 6weeks of pregnancy,
in the absence of a known chromosomal, structural or infect-
ive cause. This is consistent with the recent Delphi consen-
sus on the definition of early placental FGR [24]. Clinical
data and biological samples are collected from participants
but they do not receive any interventions.
As an extension to the EVERREST Prospective Study,
semi-structured qualitative interviews were undertaken with
women who had taken part in the UK arm of the study, to
provide insight into the experiences of women with severe
early-onset FGR who have taken part in research during preg-
nancy. This qualitative study also aimed to gain insight to the
likelihood of mothers agreeing to participate in the EVERR-
EST Clinical Trial. Qualitative telephone interviews have been
used in a range of studies including those involving challen-
ging and sensitive topics such as cancer, eating disorders, pre-
mature birth and post-natal depression [25–27].
Methods
Study aims
 To explore the experiences of women who took part
in the EVERREST Prospective Study of experiencing
a pregnancy complicated by severe early-onset fetal
growth restriction
 To explore the experiences of women who took part
in the EVERREST Prospective Study of taking part
in a research study during pregnancy
 To provide insight to the likelihood of pregnant
women agreeing to participate in the EVERREST
Clinical Trial
This was a retrospective descriptive qualitative interview
study of women who had participated in the EVERREST
Prospective Study at University College London Hospital [7].
Audio-recorded, semi-structured, qualitative telephone inter-
views were conducted using a topic guide (MH). The study
inclusion criteria were women who had taken part in the
EVERREST Prospective Study in the UK, who had delivered
their baby 1 year or more ago, were able to give informed
consent, were aged 16 years or older and were able to take
part in a telephone interview in English.
Of the 55 UK EVERREST Prospective Study participants
who were eligible to take part in the interview study, 35
were either undergoing continuing follow-up or had given
Harvey et al. BMC Pregnancy and Childbirth          (2019) 19:144 Page 2 of 13
consent to receive information by post from the study
team. Twenty-eight women were sent invitation letters, in-
cluding a participant information sheet and consent form.
A further seven women were given information about the
interview study when attending the hospital for follow-up.
With participant consent the interviews were audio re-
corded to facilitate transcription and data analysis. The topic
guide (Additional file 1) consisted of key and follow-up ques-
tions. The use of follow-up questions was determined by the
participant’s response to the initial key question. The overall
format of each interview was therefore slightly different.
However, using the topic guide ensured that all key issues
were covered.
Following the interview, the participants were sent a
£20.00 shopping voucher to acknowledge their time. The
recordings were transcribed by a professional secretarial
service. The transcripts were then checked for accuracy
(MH). Thematic analysis was undertaken using the soft-
ware package NVivo 10 (MH). The transcripts were read
to ensure familiarity with the content and context. Sec-
tions of the text were then coded. New codes were cre-
ated when the data appeared to capture something
different. The codes were then formed into broad themes
and subthemes with each broad theme containing a number
of subthemes. Once all of the transcripts had been coded,
the coding framework was reviewed and amended. As a con-
sequence, some of the original codes and sub-themes were
combined, whilst others were separated until the final frame-
work of broad themes and sub-themes was established [28].
We also examined the responses in relation to participant
characteristics to investigate whether certain opinions or ex-
periences were more common in subgroups of respondents.
In accordance with accepted qualitative methods, data col-
lection, transcription and data analysis was carried out con-
currently [29–31] until data saturation was reached.
Approval for the study was obtained from London Stan-
more Research Ethics Committee (13/LD/1254). It was pos-
sible that some women would find describing their
experiences upsetting. Consequently, the purpose of the inter-
views was clearly identified on the participant information
sheet and reiterated when the interview was arranged. Guid-
ance on where to seek ongoing support was provided. Some
women may have felt obliged to make positive responses, par-
ticularly about being part of the EVERREST Prospective
Study. However, they were all reassured that their responses
would be anonymised and it was anticipated that as the inter-
viewer (MH) was not part of the original research team that
participants would feel comfortable making their responses.
Results
Participant recruitment took place between October 2016
and July 2017. Of nineteen women who indicated that they
were interested in taking part, five could not subsequently be
contacted. Interview arrangements were made with two
potential participants who requested that the interview was
rescheduled and then could not be contacted. Consequently,
a purposive sample of 12 women was interviewed (Table 1).
This sample size reflects that used in qualitative research
where the intention is to provide insight to a range of partici-
pant experiences rather than generalise the findings to a
wider population [32]. Sample configuration compared to
that of all participants of the EVERREST Prospective Study
who were eligible to participate in the interview study is de-
scribed in Table 2.
The participants were aged between 30 and 43 years
(median 36.5 years) and were from a range of ethnic
backgrounds. The pregnancy experience that seven of
the women described related to their first pregnancy /
baby. For three of the women their pregnancy resulted
in a perinatal loss (2 stillbirths and 1 early neonatal
death). Of the nine women with surviving children,
seven were born preterm, between 25 and 34 weeks of
gestation. Eight babies were delivered by caesarean sec-
tion; the remainder were vaginal deliveries.
The interviews ranged from 16min, 50 s to 38min, 30 s
long (median 26min). All of the women answered all of
the questions. The impact of issues discussed on the par-
ticipants was monitored throughout [33]. Although dis-
cussing their experiences required some of the women to
reflect on upsetting events, none of them wanted to pause
or discontinue the interview. Four broad themes were
identified, each of which incorporates a number of sub-
themes (Table 3). There was no evidence of participants’
views differing according to their personal or pregnancy
characteristics, however this may have been because the
sample was too small to reveal such differences.
Before joining the EVERREST prospective study
The interviews began with the women discussing events
up to joining the EVERREST Prospective Study:
Fertility and previous pregnancies
Five of the women had previous successful pregnan-
cies which had gone smoothly with the babies born
well and at, or near, term. Two women had previ-
ous unsuccessful attempts at in vitro fertilisation
(IVF) and the pregnancy that caused them to join
the EVERREST Prospective Study was an IVF preg-
nancy. In their discussion both women alluded to
the emotional pressures associated with infertility
treatment:
So we conceived by IVF, it was our fifth round of
IVF. It was quite a stressful journey to fall
pregnant in the first place and we were over the
moon when we had that positive test –.
07
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Other women referred to their own health problems and
their expectation that this may impact on their fertility and
any pregnancy. In conjunction with this part of the discus-
sion, they also described finding out that they were pregnant.
I do have diabetes so I’d been seeing my GP about
my medication and I talked to him about getting
pregnant. The GP referred me to X ((hospital)) and
by the time I had that appointment, I found out
that I was pregnant. That was such a shock
((laughs)) – 09.
Early pregnancy
Before joining the EVERREST Prospective Study many of
the women had experienced the symptoms commonly asso-
ciated with early pregnancy. They had the usual antenatal
screening and most were not unduly concerned about either
their own health or that of their baby.
I had a little bit of evening sickness rather than
morning sickness but nothing irregular –.
04
Table 2 Comparison of participants in this interview study and eligible UK EVERREST Prospective Study participants
Interview study participants
(n = 12)
UK EVERREST Prospective Study participants
(n = 55)
Age (years) 36.5 (33.5 to 38) 34 (30 to 37.75)
Primigravida 7 (58%) 26 (47%)
Ethnicity: White 7 (58%) 32 (58%)
Asian 2 (17%) 11 (20%)
Black 2 (17%) 11 (20%)
Other 1 (8%) 1 (2%)
Marital status: Married 10 (83%) 38 (69%)
Living with partner 2 (17%) 13 (24%)
Single 0 4 (7%)
Data presented as median (interquartile range) and n (%)
Table 1 Participant information
Study
number
Age bracket
(years)
Parity Birth
weight (g)
Birthweight
centile [50]
Mode of
delivery
Gestation at delivery
(weeks + days)
Baby outcome
01 40–45 G1
P0
460 2nd CS 25+ 0/40 3 months total in 2 NNUs, now well
02 35–40 G4
P2+ 1
714 2nd CS 27+ 4/40 Died 9 days old
03 30–35 G1
P0
1040 Between 0.4th
and 2nd
CS 31+ 3/40 2 months total in 2 NNUs, now well
04 30–35 G1
P0
563 Between 0.4th
and 2nd
CS 27+ 5/40 3 months NNU, now well
05 35–40 G1
P0
1020 Between 0.4th
and 2nd
CS 31+ 5/40 2 months total in 2 NNUs, now well
06 35–40 G5
P2+ 2
2030 Between 0.4th
and 2nd
Vaginal 37+ 3/40 Well
07 30–35 G1
P0
550 Below 0.4th CS 28+ 6/40 3 months total in 2 NNUs, now well
08 35–40 G1
P0
2440 Between 2nd
and 9th
Vaginal 38+ 1/40 Well
09 35–40 G1
P0
1190 Below 0.4th CS 34+ 6/40 1 month in NNU, now well
10 30–35 G2
P1+ 0
1053 Between 2nd
and 9th
CS 31+ 2/40 2 months total in 2 NNUs and 1 children’s
hospital, now well
11 35–40 G5
P3+ 1
328 Below 0.4th Vaginal 25+ 0/40 Stillbirth
12 35–40 G2
P1+ 0
472 Below 0.4th Vaginal 28+ 3/40 Stillbirth
G gravida, P para, CS caesarean section, NNU neonatal unit
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Finding out something was wrong
The women continued by describing when problems in
the pregnancy were identified. They explained what hap-
pened, how they were told and their reaction to the in-
formation. For some women confirmation of their baby’s
growth restriction coincided with the onset of
pre-eclampsia, vaginal bleeding or the identification of
poor placental / uterine blood flow. For others, it was
identified that their baby was smaller than expected dur-
ing routine ultrasound scanning.
Everything was going really smoothly until our 20 week
scan … … … … they said that the baby was curled up
in a ball so they couldn’t do the measurements but
they said that happens. So we weren’t so worried at
that point and then a couple of weeks later the same
thing was happening but the measurement that they
could take they said that the baby was a bit small and
they referred us to fetal medicine – 07.
All of the women talked about who first told them
about the FGR and how they were told. Whilst most
could not remember their name, they were able to de-
scribe their role. The women could all clearly recall their
reaction to the news that their baby was smaller than ex-
pected. They described feeling ‘devastated’, ‘worried’,
‘upset’, ‘floored’ and ‘shocked’. One said she felt cursed,
another said the news came as a ‘bomb-shell’.
Oh devastated … … Absolutely devastated. You know,
because we’d so much obviously longed to have the
child and that. And then to be told, you know, it’s, so
it’s almost, like, you know, you’re thinking, you know, if
someone’s put a curse on you or something. Like, you’ve
been through so much actually to get pregnant in the
first place – 01.
Then I think, I don’t remember when, 24 weeks or so,
one of the consultants said his liver blood flow was not
right. So then it was even worse because he said that
my baby might die at any time … … …………… … Yes,
that was very stressful because at that point I was
feeling his kicks and yes, that was really bad. I had to
take some time off work. I couldn’t tell it to anyone,
these things – 03.
Some women experienced a more delayed response
because they could not initially take in what they had
been told. Others were more accepting or did not at first
fully appreciate the severity of the situation.
I think it took us probably until the next day really to
really realise how upset we were. I think our initial
reaction was acceptance and right ok and probably a
bit shocked and then trying to work out what it meant
really, which I think took some time and perhaps we
didn’t really work it out until she was born. But we
certainly took a bit of time, yeah – 04.
Despite feeling worried and concerned by the news,
most women appreciated being given frank, realistic and
honest information in a sympathetic manner. They were
also grateful that their baby’s problems had been picked
up early in the pregnancy.
I just thought, ok, well, I felt grateful that I was being
referred to X ((hospital)) because I thought, oh, good,
I’m going to a specialist place, I kind of felt lucky that
it had been picked up – 08.
Conversely a few women described being given the
news in a way that could be deemed less supportive.
Did he say that to you in those words? ((that the baby
might die at any time)) – MH.
Yes, at the scan. It was like not really oh, just telling
me the fact that, he may die, what can we do? I
understand, you know, a doctor but they could have
been a bit softer – 03.
Table 3 Broad themes and subthemes
Broad theme Subthemes
Before joining the EVERREST Prospective Study ▪ Fertility and previous pregnancies
▪ Early pregnancy
▪ Finding out something was wrong
▪ Transfer of care
Participating in research ▪ Joining the EVERREST Prospective Study
▪ Being part of the study
▪ Involvement in other research
Information and support ▪ Information and support experiences involving other health care professionals
▪ Seeking information
▪ Support networks
Looking back and looking forwards ▪ Making sense of what happened
▪ Looking to the future
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Some of the women were on their own when they
were told of their baby’s growth restriction. This was
usually because they had been asked to attend a sec-
ond scan and were unaware of the reason for this.
The impact of being given the news on their own
was for some women compounded by a lengthy jour-
ney home afterwards. As a consequence, they made
sure that they were accompanied by a family mem-
ber or friend to all future scans.
I was on my own. It was really, really hard – 11.
It was just everything as normal, until the 20-
week scan in which case they obviously flagged it
up as a bit small, and they didn’t tell me, they
just asked me to come back, that was my hos-
pital, asked me to come back the next week. And
then I came back the next week on my own just
thinking it’s because they hadn’t taken enough
measurements or something, and then that I was
told, oh, it was small. So unfortunately I didn’t
come back with anybody because I thought it was
just collecting some more data, but that was obvi-
ously quite a shock, that they didn’t let me know
why they were asking me back, because I was on
my own then – 08.
Transfer of care
Whilst a few of the women were under the care of
the study site throughout their pregnancy the re-
mainder were transferred there when the severe
early-onset FGR was identified. These referrals rein-
forced the seriousness of the situation. However,
they were reassured by the reputation of the study
site and felt they would receive optimal care from
specialist staff who had access to better facilities.
They also believed they would be more likely to
have a live baby.
… … I think, I don’t know, probably realised the
severity of it. So we were obviously, then I know,
I’ve heard of, I know X ((hospital)) and that. But
on the other hand, like, then I thought, actually
well I’m probably in the best place, because
they’ve probably got a bit more specialist staff
there as well – 01.
I think, so a mixed reaction. I think it was a, oh
my gosh, what is going on? What’s happening? It
must be something bad if I’m being transferred
there, but at the same time it’s like a, I’m going
to the best place where they know a lot, so it
should be okay – 02.
Participating in research
During the interview, the women talked extensively
about being involved in research generally and the
EVERREST Prospective Study specifically.
Joining the study
The women often could not recall who specifically had
recruited them to the EVERREST Prospective Study.
However, they all remembered being told that taking
part may help other families in the future. When decid-
ing whether to participate, some drew on their own
knowledge of research. Whilst some decided very
quickly, others needed more time and this often in-
cluded discussing the study with family and friends.
None of participants felt pressurised to take part.
Yeah, it was X ((member of research team)), she was
so lovely. She was really, ‘cause she was really helpful
and supportive all the way through … … … It was an
instant decision. It was just sort of, it was just
something that we thought if it’s going to help
somebody else, then we’re happy to do it – 02.
I thought it was a good idea, I thought they might find
a cure … ..I thought about it for a couple of minutes –
11.
Being part of the study
The women described the positive aspects of the way
the EVERREST Prospective Study was conducted. Re-
search team members were described as being ‘under-
standing’, ‘kind’, ‘supportive’, ‘helpful’, ‘sympathetic’ and
‘accommodating’. When giving examples of positive in-
teractions some health professionals were specifically
named. It was important to the women that the remem-
bered their name and were ‘upbeat’ in their approach.
I’d have to say I think both my husband and I feel
that we were extremely well treated, the care we were
given both by the fetal medicine team, perhaps even
the fetal medicine team in particular and the
EVERREST study was very, very good. I think we both
felt it was done with a good degree of care and we’re
very grateful to the people involved – 03.
Whilst a few women said there was no direct advan-
tage to them being part in the EVERREST Prospective
Study, most thought there were a range of benefits. They
felt they had received better care, additional and more
detailed monitoring and prompt referrals. Being part of
the research therefore enabled them to learn more about
their baby. They also felt they had more opportunity to
ask questions and felt this was empowering. Being part
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of the study also helped them to feel less isolated and
that they were contributing to something important.
That is one thing to add that I think the fact that you
know, that during that time, that there is some
medical research taking place, that people are working
on it does give some comfort I think. Perhaps it does
make you feel less isolated at points as well, that it’s
being looked at globally essentially, it’s across
countries. Perhaps you also do feel less afflicted and
perhaps there is that element to it – 03.
It was apparent that most of the women could not dis-
tinguish between fetal medicine staff and research team
members and where their roles overlapped. Similarly,
most women were unclear what the usual care pathway
was when a growth restricted pregnancy was confirmed
and the specific elements of the EVERREST Prospective
Study. A few women acknowledged their uncertainty
about this.
I believe that X ((doctor)) and her team saved my
baby’s life, the decisions they made when they decided
when to give me the steroids and when it was best for
her to be born. But I don’t know if their decision
making was related to the extra information they
gathered as part of EVERREST or whether they would
have made those same decisions regardless of me being
part of EVERREST – 07.
Some women identified other more peripheral benefits
of taking part in the research. This included being able
to take a day off work to attend appointments, being
able to take family members with them, combining ap-
pointments with social events and the opportunity to get
involved with other related activities.
I did a ((radio)) programme with them ((the research
team)) as well, you know, they were talking about
growth restriction. … …. I got involved with the
programme – 01.
Negative factors associated with being part of the
EVERREST Prospective Study mostly related to logistical
challenges such as getting time off work, the cost of add-
itional travel to appointments and arranging child care.
However, these negative issues were felt to be minimal
and were outweighed by positive aspects.
The travelling was tiring but I always came back calm
and happy – 06.
The women talked extensively about why they took
part in the research. Initially they gave altruistic
reasons saying that they wanted to help to improve
care for other families. They also felt it was a way of
‘giving something back’ for the care they had re-
ceived. One mother felt she was an unusual case and
so had something specific to offer the research.
Happy to take part in anything that’s going to
help anybody else further along the line, so I had
no problems with doing it or taking part in
anything at all. If it benefits somebody else, very
happy to – 02.
As the discussion continued, the women talked
about more personal benefits that influenced their
decision to participate. They thought they would
have more information and greater reassurance. They
also thought they would receive better care, even
though within the recruitment process it was made
clear that this was would not be the case.
I guess we probably made the decision thinking if
we join the study that we might get better care, I
know they always say that’s not the case, the care
will be the same. But all of those things were said
to us so it didn’t help, it didn’t stop me thinking
that we might get better care – 07.
The women were asked if they had understood at
recruitment what participation would involve. Most
said this had been as they expected. Whilst a few
felt that they had not fully understood, this did not
concern them and they were pleased to have taken
part.
There haven’t been any surprises. I probably didn’t
fully understand what was involved at the time, just
because I’m a first time mother and was involved in
the pregnancy, so at the time I just thought if it helps
X ((hospital)), I’ll help – 05.
The women were asked if there was anything that the
research team could have done differently. Whilst most
did not identify any changes, a few made some sugges-
tions. These included more face-to-face discussion ra-
ther than the provision of written information at
recruitment, more updates and guidance on accessing
information about growth restriction.
I did a lot of research online about small babies and
that kind of thing … … … .. I think I would have liked
to have had or been given, or been pointed in the
direction of credible studies and ones that were well
thought of, rather than me having to try and find
them myself – 08.
Harvey et al. BMC Pregnancy and Childbirth          (2019) 19:144 Page 7 of 13
Involvement in other research
Although the focus of the interview was the EVERREST Pro-
spective Study, a few women talked about being involved in
other research not related to the EVERREST Project. They
described reaching a threshold when asked about their or
their baby’s potential participation in other studies. In declin-
ing other research, they felt the need to protect their baby,
particularly if their child was preterm. They also indicated
that research teams should be sensitive when approaching
families about studies at a difficult time or when they were
already taking part in other research.
I think by the time she came to the end of her
time in the neonatal unit we’d been asked to join
a couple of other additional studies and I have to
say I did get to the point where I started saying
no. Because at that stage I felt here’s this tiny
baby we were desperately trying to get her home
and I felt she’d had enough. And actually I felt
we’d had enough … … I think we reached the
point by the end of that, what was nearly four
months where we just thought actually we want to
protect our child and we feel like we’ve given
enough. I think the EVERREST was not a problem
– 04.
The women also talked about the likelihood of
getting involved in other research in the future.
They felt their understanding of the importance of
research and their positive experience with the
EVERREST Prospective Study meant they would at
least consider taking part in other studies.
I suppose I would judge each study as it came
along and see what happened, but most of the
time I’d be happy to take part in mostly whatever
it is that’s being offered – 02.
As part of this discussion the women talked about
the likelihood of them agreeing to be involved in the
EVERREST Clinical Trial. This would require them to
consent to the possibility of having maternal uterine
artery adenovirus VEGF gene therapy. A few women
were aware of this planned research. Some women
felt the question was too hypothetical and that they
would only really know how they would respond
when faced with the situation. Conversely, others felt
confident that they would agree to participate. This
was because the study would be building on the work
of the EVERREST Prospective Study, by a team of re-
searchers they knew and trusted.
I think if I’ve already helped by taking part in the
EVERREST study, I mean obviously the next.
stage for you guys is to be able to make a comparison
… .. So I would be happy to help – 05.
For now I will say yes, because if there is anything,
God forbid I’m in this situation again, anything to
help my baby, while in there. I’ll be happy to have it
because at the end of the day … … if there’s anything
to help her, yeah, I’d be happy with that – 10.
Other women were more uncertain because of the un-
known impact on the baby or the study outcome. They
also felt that they would not want to jeopardise what po-
tentially for them would already be an ‘at risk’ pregnancy.
Like I said, I don’t want to take anything that could
harm by baby, my baby was small because of my
diabetes and all that – 09.
Only if it wasn’t going to harm the baby – 06.
Some of the women went on to say that they would
only agree to take part if it was guaranteed that they
would receive the study intervention (rather than a pla-
cebo or conventional treatment) or if the intervention
had previously been tested on humans.
I think if I was in that position then I would want to
have the gene therapy, but I wouldn’t want to be
offered a placebo, I would only want to know I was
agreeing to have it or not to have it; and I think I
probably would agree to have it – 08.
Information and support
Within the narratives, the ways in which health care
professionals provided more general information and
support was an important factor in shaping the women’s
overall experiences. They also talked about proactively
seeking information and support themselves.
Information and support experiences involving other
health care professionals
Some women gave mixed reports of information pro-
vided by health care professionals who were not part of
the research team. In some cases they were concerned
about an apparent lack of knowledge or being given
contradictory information.
I was just left kind of thoroughly unimpressed with her
kind of knowledge of my, well, she hadn’t read any of
my notes, and her responses were very, oh, we’ll do
this, and we would do that, but only based on what
I’d told them, not kind of based on her having looked
at my notes and thought about it or anything like that,
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I felt. And that appointment kind of coincided with I
think it was kind of, or me or someone saying about
transferring my care, and so that kind of just cemented
the decision – 08.
However, the same participant also described a posi-
tive interaction she had with another health care
professional.
After every scan the head midwife ((at local hospital))
who originally referred me to X ((hospital)), she
phoned me just to kind of catch up how I’d got on and
that kind of thing. I thought that was really nice – 08.
Seeking information
In addition to the information from health profes-
sionals, most women had also accessed information
from other sources. This included speaking to family
and friends with specialist knowledge, consulting
other health professionals and accessing information
via the Internet. With regard to the latter, they said
it was difficult to access appropriate and reliable in-
formation. Consequently, the information that they
gained was not always helpful.
I spoke to my aunt who is also a midwife and she
started giving me scenarios of other parents and
friends that she knows who have been given negative
reports about their scan. By the end of the day, the
baby came out perfectly well. But, you know, I just
suppose she was trying to reassure me about what
might happen – 10.
So that’s why I decided to go in the private as well to
make sure, to have more than one answer, more than
one, not because I don’t believe in NHS, but I just like
to have more information as I can, and to see if I have
any information like oh, your baby okay and your
pregnancy’s fine – 12.
Support networks
The women described support networks that they
accessed and the importance of their partner and
their wider family. For one woman her church pro-
vided support whilst another found talking to a psy-
chotherapist helpful.
I have a family. Massive family network. My husband’s
family and my family, as soon as they knew what had
happened, my parents travelled down from X
((location)). X’s ((husband’s)) family in and around X
((location)), so we were, you know, there was,
inundated with support. So in that sense, no there was
a load of support – 01.
Looking back and looking forwards
As the discussion continued, the women reflected back
on their experiences and also looked to the future.
Making sense of what happened
The women talked about the birth and their baby’s sub-
sequent care. They described the impact of their experi-
ences on their health and emotional wellbeing as well as
the impact on family members and particularly their
other children. They also spoke about accepting what
had happened and ‘moving on’.
The women were clearly able to recall events sur-
rounding the birth of their baby. In most cases the deliv-
ery was prompted by a deterioration either in their own
health or that of the baby. Although for many of them a
premature birth had been anticipated, they nevertheless
felt ‘shocked’, ‘anxious’ and ‘stressed’ when this actually
occurred. One woman having been told her baby needed
to be delivered early, encountered additional anxiety
when the delivery was delayed due to a lack of neonatal
intensive care resources.
I think all the way along X ((doctor)) had said in this
particular case she would feel uncomfortable going
much beyond 28 weeks, because I think she felt it was
a very fragile situation. So, nevertheless I still felt very
shocked when someone turned round and said, right I
think we’ll deliver this baby tonight – 04.
Of the ten live born babies, eight required neonatal
unit (NNU) care, five of whom were cared for in more
than one NNU. One baby died at 9 days of age. The
women described their baby’s time in the NNU as a ‘roll-
ercoaster’. They talked of their distress on being sepa-
rated from their baby and being surrounded by heathy
babies on the postnatal ward. Some women valued the
extra time in hospital that they were able to spend with
their baby, whilst others thought they had been dis-
charged home too soon. Women whose baby was cared
for in more than one NNU had mixed feelings about
this. Some were initially, and remained reluctant about
their baby being transferred, whilst others soon adapted
to the new environment.
What was bad was after I had been discharged from X
((hospital)) and my daughter was still there, going
every day with my caesarean – 10.
I didn’t like the idea of that ((baby transferred to
another NNU)) at all. I knew it had to happen
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because X ((hospital)) is very much high dependency,
and X ((hospital)) was nearer home, and I was
travelling in every day, but it’s quite, it’s, as for any
mum, it was quite traumatic –.
05
The women went on to reflect on to their own health
after the birth. They talked about recovering from a cae-
sarean section, the ongoing management of their health
problems and their emotional wellbeing after the birth.
I suppose, you know, I just went through a difficult
time mentally. And, you know, to be fair that’s not
gone away. You know, then X ((baby)) was in hospital
this year with pneumonia, no last year with
pneumonia at Eastertime. And then I just find that
now it’s just triggered any, so X ((baby)) what I went
through with X ((baby)) has just triggered something in
me that any, sort of, major change in my life or
trauma, it gets me, you know, it’s gets me back to that
state again and I’ve got to really be careful that, you
know, at the time, recognise the signs early on and
take the necessary actions really – 01.
Some of the women reflected on the impact of their
experiences on their other children. In the main, they
felt events had a negative impact, particularly if the baby
had died.
I’ve tried to explain to him ((other son)) every day. Of
course he feels like he’s supposed to have a baby
brother, everybody’s got a brother or sister and I’ve not.
It’s like that. But I just explain to him I had operation
so they took it ((the baby)) out from my uterus, my
uterus is new, so in one year time I can have another
baby if I desire. So it’s something like he can have a
hope. If God gives me this opportunity I will have
another baby in the future – 12.
Within their reflection, the women discussed their un-
derstanding of the reasons for the growth restriction.
Some had been told this was due to placental insuffi-
ciency, chromosomal anomalies or pre-eclampsia.
Others said they had not been given a reason and sur-
mised the likely causes. One mother wondered if the im-
pact of invasive procedures during her pregnancy was a
possible cause.
I still don’t know why, I was worried at first that I’d
picked something up in Africa – 06.
When reflecting on their experiences, for some women
their religious faith or belief in fate brought comfort and
acceptance. Others felt ‘lucky’ and ‘grateful’. They also
felt something positive had come out of their experience
because they had been able to contribute to the EVERR-
EST Prospective Study. Several women felt it was now a
time for them to ‘move on’. One woman whose baby
died in utero felt she had to ‘keep on going’ for her other
child.
I think, you know, I was one of the lucky ones and
we’ve come out of it the other side. And I’m sure there
are stories where, you know, it’s not been such a happy
ending. You know, so I just think, do you know what,
it’s what’s meant to be is meant to be. And what your
destiny will be, isn’t it? And so that, you know, that,
it’s one of those things, just a part of life, isn’t it,
unfortunately. So sometimes, you do question why you?
Because you went through so much to get there in the
first place. But, you know, again you’ve just got to, now
looking back you’re just grateful for where she is now –
01.
Looking to the future
In looking forwards, some women considered the possi-
bility of having another baby. All those who thought
they might, felt reassured that they would be closely
monitored.
I went there ((hospital)) last week, they gave me some
information about if I get pregnant again – 11.
One of the women who had previously experienced a
neonatal death was pregnant at the time of the inter-
view. She expressed her anxiety about the outcome even
though she had been reassured that all was well:
Emotionally it’s sort of all mixed because of my last
pregnancy, and the little one not making it. I know
that this one is fine and there are no issues, hopefully,
so far, but there’s always like that underlying anxiety –
02.
The women also considered the health of their baby
now and their baby’s likely health in the future. Some
babies had ongoing health problems which usually re-
lated to prematurity. All babies continued to be small.
Whilst some women remained concerned about this,
others were more sanguine. Part of the discussion in re-
lation to this focused on their child’s current weight and
possible weight gain in the future.
He was putting weight on really well ((in the NNU)),
he went up from 0.4 centile to second centile quite
quickly. The thing is though, he’s quite funny with food.
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If he’s not in the mood or the teeth are hurting, he
won’t eat. But in the nursery, he eats everything. I
wouldn’t say there was something wrong with him
physically. It’s just he’s been playing with me – 03.
Discussion
The qualitative approach taken in this study was an ap-
propriate way in which to learn about the experiences of
women of having a pregnancy complicated by growth re-
striction and of EVERREST Prospective Study participa-
tion. Conducting the interviews by telephone was an
effective and practical way of exploring the women’s ex-
periences [25, 34]. This interview study provides valu-
able insights to the emotional impact of having a growth
restricted pregnancy, the challenges the women faced
when their care was transferred, their information and
support needs, their perceptions of the care they re-
ceived and their experiences of being part of a research
study. The women spoke frankly and whilst acknowledg-
ing the distress and despair they felt at times, they also
seemed to enjoy talking about what happened to them.
The experience of having a growth restricted pregnancy
remained very real and for some had a lasting psycho-
logical impact. The women talked openly about their
worries, concerns and fears when the growth restriction
was confirmed and particularly about the likelihood of
their child surviving or of preterm birth. The women
often referred back to the exceptional care they had re-
ceived. Those whose experiences resulted in a stillbirth
or neonatal death seemed to appreciate the opportunity
to talk about their baby.
The women talked in detail about why they had agreed
to take part in the EVERREST Prospective Study. In com-
mon with the findings of other similar studies they mainly
gave altruistic reasons for their participation [35–37]. They
often commented on ‘giving something back’ and were keen
to influence the future provision of care for women and fam-
ilies facing a similar situation. In making the decision to par-
ticipate, they felt the study was unlikely to impact on either
them or their baby in a negative way. Some women also
talked about the personal benefit to them and particularly
having access to more information and support and feeling
less isolated at a difficult time. They generally assumed they
would receive better care [38, 39]. Although in some cases
participation presented additional obstacles [35] such as
travel and organising child care, all of the women were
pleased to have taken part.
There were a number of aspects of the EVERREST Pro-
spective Study that the women valued which maintained
their engagement. This included the way in which they
were recruited, ongoing contact with the research team,
feeling that they were part of something important and re-
ducing their feelings of isolation [35]. The more negative
encounters experienced by some of the women with other
health care professionals, reinforced their trust in the
EVERREST Prospective Study research team.
Issues surrounding information giving and information
retrieval were a large component of the interviews. This
is unsurprising given that pregnancy, childbirth and the
early postnatal periods are key times when women and
their partners seek information, particularly if they are
first-time parents [40, 41]. For the women in this study,
the growth restriction, potential preterm birth and con-
cern about their baby’s survival heightened their need
for information. The ways in which information was ini-
tially and subsequently given about the growth restric-
tion were key aspects of the women’s experiences. As
has been identified in other studies of clinician-service
user communication, the women had differing informa-
tion needs [42–44]. Whilst they generally preferred frank
information given in a direct way, a few preferred a softer
approach. This indicates that information-giving requires
a flexible approach from health care professionals in order
to ensure that the strategies adopted suit the needs and
wishes of individual woman and their families [44, 45].
Two interlinked issues relating to communication and
information-giving at the diagnosis of severe early-onset FGR
were pertinent to the narratives of some of the women. The
first was not understanding why they had been asked to come
back to the hospital for a repeat scan. As a consequence some
women returned for this follow-up appointment on their
own. The second was being given distressing information
when they were on their own and the added impact of having
to travel home alone afterwards. The health care professionals
may have not wanted to unduly or unnecessarily alarm the
women about the reasons for the follow-up scan. Neverthe-
less, these issues highlight the need for health care profes-
sionals to carefully consider what information they give about
follow-up appointments and the value of women being be ac-
companied to such appointments.
The internet was used as an information source by a num-
ber of the women and their partners to clarify information
they had not fully understood, to access more detailed infor-
mation and to inform their decision-making [46, 47]. How-
ever, the limitations of using the internet as an information
source were acknowledged and have previously been recog-
nized [44, 48]. Family and friends were other useful informa-
tion sources of information [40]. This is a factor for health
care professionals to consider because this could be a source
of contradictory information.
It is important to acknowledge factors that may have
affected what was reported. None of the women had dif-
ficulty recalling what had happened. Indeed, interview-
ing participants at least one-year post-experience
enabled them to reflect on their experiences as a whole
rather than focusing solely on their immediate reactions.
However, this meant for some women that the entirety
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of their experience may have been shaped by other fac-
tors such as having a preterm baby requiring neonatal
intensive care. Nevertheless, diversity within the sample
enabled a range of experiences to be described [49]. As
in any study, it is only possible to reflect the opinions
and experiences of women who agree to participate. It is
possible that the views of women who did not take part
in this interview study may have differed from the views
of those who did.
Conclusions
This qualitative study provides insight to women’s experi-
ences of having a growth restricted pregnancy. Their
retrospective reports and reflections illustrate their recall
and understanding of what had happened, the impact of
the care and support they had received and their experi-
ences of being part of the EVERREST Prospective Study.
The interviews also facilitate understanding of women’s
perceptions of care and highlights aspects of care delivery
and being part of a research study that were important to
them. Interviewing women at this time point, when they
have had time to reflect on earlier events, resulted in a
more balanced and thoughtful view of their experience. A
strength of this qualitative work is that it goes beyond the
women’s immediate reactions to their experiences.
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